Departments of Molecular Design and Informatics, MSD, P. O. Box 20, 5340 BH, Oss, The
J Biol Chem. 2012 Jun 8;287(24):20333-43. doi: 10.1074/jbc.M111.308403. Epub 2012 Apr 25.
We present here the x-ray structures of the progesterone receptor (PR) in complex with two mixed profile PR modulators whose functional activity results from two differing molecular mechanisms. The structure of Asoprisnil bound to the agonist state of PR demonstrates the contribution of the ligand to increasing stability of the agonist conformation of helix-12 via a specific hydrogen-bond network including Glu(723). This interaction is absent when the full antagonist, RU486, binds to PR. Combined with a previously reported structure of Asoprisnil bound to the antagonist state of the receptor, this structure extends our understanding of the complex molecular interactions underlying the mixed agonist/antagonist profile of the compound. In addition, we present the structure of PR in its agonist conformation bound to the mixed profile compound Org3H whose reduced antagonistic activity and increased agonistic activity compared with reference antagonists is due to an induced fit around Trp(755), resulting in a decreased steric clash with Met(909) but inducing a new internal clash with Val(912) in helix-12. This structure also explains the previously published observation that 16α attachments to RU486 analogs induce mixed profiles by altering the binding of 11β substituents. Together these structures further our understanding of the steric and electrostatic factors that contribute to the function of steroid receptor modulators, providing valuable insight for future compound design.
我们在此呈现了孕激素受体(PR)与两种混合配体调节剂复合物的 X 射线结构,其功能活性源自两种不同的分子机制。与激动剂状态的 PR 结合的 Asoprisnil 结构表明,配体通过包括 Glu(723)在内的特定氢键网络有助于增加螺旋-12 激动剂构象的稳定性。当全拮抗剂 RU486 与 PR 结合时,这种相互作用不存在。与先前报道的 Asoprisnil 与受体拮抗剂状态结合的结构相结合,该结构扩展了我们对化合物混合激动剂/拮抗剂特性背后复杂分子相互作用的理解。此外,我们还呈现了 PR 在其激动剂构象中与混合配体化合物 Org3H 结合的结构,与参考拮抗剂相比,其拮抗活性降低而激动活性增加,这是由于 Trp(755)周围的诱导契合,导致与 Met(909)的空间冲突减少,但在螺旋-12 中诱导与 Val(912)的新内部冲突。该结构还解释了先前发表的观察结果,即 RU486 类似物的 16α 连接通过改变 11β 取代基的结合诱导混合特性。这些结构共同加深了我们对甾体受体调节剂功能的立体和静电因素的理解,为未来的化合物设计提供了有价值的见解。